For many patients, by the time stomach cancer is diagnosed, it has already spread, or metastasized, throughout the abdomen. Newer chemotherapy and immunotherapy treatments have made it possible for patients with advanced stomach cancer to live for an average of 10 to 17 months after diagnosis.
The UT Dallas and UT Southwestern researchers hope their enhanced therapy can improve patients’ prognoses.
“There is a dire need for treatments to help people with advanced stomach cancer live longer,” Obaid said. “If successful, our approach ultimately can help patients with stomach cancer live longer after the cancer has spread.”
The approach uses lab-designed molecules and far-red or near-infrared light to “prime” the immune system to help it attack stubborn cancer cells, said Dr. Girgis Obaid, assistant professor of bioengineering in the Erik Jonsson School of Engineering and Computer Science.
For many patients, by the time stomach cancer is diagnosed, it has already spread, or metastasized, throughout the abdomen. Newer chemotherapy and immunotherapy treatments have made it possible for patients with advanced stomach cancer to live for an average of 10 to 17 months after diagnosis.
No comments:
Post a Comment